Objectives The objective of this study was to determine the relationship between chronic kidney disease [CKD; measured using cystatin C-based estimated glomerular filtration rate (eGFR)] and abnormal ambulatory blood pressure (including nocturnal dipping) in healthy older adults. Further, this study aimed to assess the agreement between clinic and ambulatory blood pressure monitoring.
Introduction
Ambulatory blood pressure monitoring (ABPM) provides data on the average blood pressure over 24 h, including wake and sleep values and diurnal patterns. It is considered by many to be the diagnostic standard against which other blood pressure modalities should be compared [1, 2] . Individuals with confirmed out-of-office hypertension and those with less than 10% diurnal variation (nondippers) suffer increased morbidity and mortality [3, 4] . A recent systematic review on the improved accuracy of hypertension diagnosis has confirmed that ABPM is more closely linked to cardiovascular disease outcomes than standard clinic blood pressure measurements, and the US Preventive Services Task Force has released a draft recommendation to use ABPM routinely in all patients with a positive screen for hypertension in clinic blood pressure measurements [5] [6] [7] . Whereas this change would vastly increase the frequency with which this measure is utilized and interpreted in clinical practice, populations with comorbid conditions including chronic kidney disease (CKD) were excluded from the data used in this analysis.
Those with CKD are more likely to have clinically apparent hypertension, either as a causative factor for CKD or as a consequence of longstanding CKD. Further, advanced CKD (stages IV and V) is associated with abnormal nocturnal dipping [8] . Although mild decrements in kidney function, as measured by cystatin C-based estimated glomerular filtration rate (eGFR cys ), have been associated with increased rates of hypertension [9] , to our knowledge few studies have examined whether mild decrements in kidney function are associated with abnormal 24-h blood pressure patterns. Cystatin C-based eGFR is an important metric for these studies, because of its increased sensitivity at higher ranges of eGFR [10] and its utility in older adults, for whom creatinine may overestimate kidney function in the setting of lower muscle mass [11] .
Furthermore, agreement between ABPM and clinic blood pressure measurements is variable and may differ in general populations [12] , as well as in those with advanced CKD [13] ; however, this question has not been examined closely among older adults, nor has it been investigated in the context of cystatin C-based eGFR measures. In older adults, cystatin C has the advantage of being less influenced by muscle mass or overall health status and serves as an early marker of decreased eGFR [10, 14] . More work is needed, then, to understand the role ABPM plays in identifying hypertension among individuals with mild kidney disease.
In the present cross-sectional study, we examined the relationship between eGFR cys and ambulatory blood pressure parameters in a cohort of generally healthy, community-dwelling older adults in San Diego. We hypothesized that lower eGFR cys would be associated with abnormalities in blood pressure parameters, including nondipping and ambulatory hypertension, given the sodium and water retention seen in CKD and the known higher prevalence of nondipping in those with advanced CKD. We hypothesized that this association would be stronger using eGFR cys than for kidney dysfunction as measured by creatinine (eGFR cr ). Finally, because the diagnosis of hypertension is overwhelmingly established based on clinic blood pressure measurement at present, we evaluated the agreement between ambulatory and clinic blood pressure measurements to determine the precision and accuracy of this approach in this population and tested whether it differed by eGFR cysbased CKD status.
Methods

Study participants
Data were collected from a subset of participants originally enrolled in the San Diego Population Study (SDPS). A description of recruitment and study design for the original SDPS has been published previously [15] . In brief, SDPS is an ongoing observational study designed to examine the prevalence and incidence of chronic peripheral venous and arterial disease in a population of healthy, asymptomatic adults. Participants enrolled in the original 1994-1998 study (n = 2408) were current and former employees of the University of California, San Diego; 1103 returned for another visit between 2006 and 2011. We sent invitation letters to participants who had San Diego County addresses on file and had indicated willingness to be contacted for future studies (N = 944); 354 participants responded and agreed to participate in the current study between January 2012 and June 2013. Participants were at least 55 years of age, living independently, and able to provide their consent for the study. During a single study visit, we carried out relevant assessments including 24-h ABPM, measurement of kidney function using cystatin C, creatinine, and albuminuria, and assessment of physical and cognitive function. Participants were excluded from the current analysis if they lacked serum cystatin C measurements (n = 6) or did not undergo full 24-h ABPM (n = 14).
Kidney function
Serum specimens were collected from all participants at the time of the study visit. Serum creatinine was measured immediately at the University of California, San Diego Center for Advanced Laboratory Medicine, using a standard, calibrated creatinine assay. Serum specimens were subsequently stored at − 70°C. Serum cystatin C was measured at the University of Minnesota Advanced Research and Diagnostic laboratory using a Gentian assay on a Roche COBAS 6000 analyzer (Roche Diagnostics, Indianapolis, Indiana, USA). Glomerular filtration rates were estimated (eGFR) using the three recently developed CKD-EPI equations for creatinine, cystatin C, and the combination of the two [10] . Participants were categorized by the presence of CKD based on eGFR cys less than 60 ml/min/1.73 m 2 or eGFR cr less than 60 ml/min/ 1.73 m 2 .
Covariates
Participant characteristics were obtained through a selfreported questionnaire and included information on age, sex, race, smoking and alcohol use, and medical conditions. Alcohol use was defined as current use; tobacco use was defined as current, former, or never. Personal history of hypertension was defined by self-report or by active use of an antihypertensive agent without an alternative indication. Diabetes was defined by self-report or through active use of insulin or hypoglycemic agents. Prevalent cardiovascular disease was defined as a history of myocardial infarction, congestive heart failure, stroke, or transient ischemic attack. Height and weight were measured during the study visit and were used to calculate BMI (reported in kg/m 2 ). An abnormal Epworth Sleepiness Score was defined as any score of 10 or higher of 24 possible points based on previous literature identifying such a score as predictive of excessive daytime sleepiness [16] .
Blood pressure
Blood pressure was initially measured during the study visit by performing three seated measurements using an automated blood pressure cuff (Dynapulse, Vista, California, USA) after 5 min of seated rest. The average of these three measurements was used for analysis; the first measurement was not eliminated from the analysis as recent studies have found no statistically significant difference between this measurement and subsequent measurements [17] . ABPM was then initiated using a SpaceLabs 90217 monitor (SpaceLabs Healthcare, Snoqualmie, Washington, USA). The first ambulatory measurement was obtained during the study visit to confirm proper cuff placement and machine accuracy. Blood pressure was measured every 20 min while awake and every 60 min while asleep for a total duration of 24 h; measurement intervals were preprogrammed based on subject-anticipated sleep periods, and sleep and wake intervals were confirmed by in-person interviews on the morning after overnight monitoring. Daytime nap, if it occurred, was not considered as part of a sleep period. If there were discrepancies between the anticipated and actual sleep periods, analysis was carried out on the basis of self-reported sleep periods during in-person interviews after completion of overnight monitoring. Values collected during ambulatory monitoring were then averaged and reported as overall, wake, and sleep mean systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse pressure. Blood pressure values collected during the sleep period were compared with those collected during the wake period to calculate the percent change between the two, known as 'dipping', for both SBP and DBP. We considered 14 daytime and six nighttime readings to ABPM readings to be an adequate ABPM report. Blood pressure values were also used to calculate the ambulatory arterial stiffness index and the average real variability, reflecting arterial stiffness and reading-to-reading variability, respectively [18, 19] .
Statistical analysis
Baseline characteristics of participants were summarized by eGFR cys status. Differences between CKD statuses were determined using t-tests for continuous variables and χ 2 -tests for categorical variables. Pearson's correlation coefficients were calculated for eGFR cys and eGFR cr versus clinic and ambulatory blood pressure measurements. Simple linear regression was performed to examine the relationship between eGFR cys and eGFR cr and various blood pressure measurements (clinic SBP, DBP, and pulse pressure, and mean ambulatory SBP, DBP, pulse pressure, and dipping). We chose covariates based on biological plausibility or statistical significance in univariate modeling. Staged multivariable linear regression was subsequently performed to account for (i) age and (ii) sex, race, BMI, history of hypertension treatment, diabetes, cardiovascular disease, smoking history, and abnormal Epworth score. We used stepwise regression to identify individual confounders with particularly notable effects on the models. Similarly, we used linear regression to examine the associations of CKD cys and CKD cr with in-clinic and ABPM metrics, with a parallel set of nested models. The prevalence of 'dippers', again defined as individuals with a diurnal variation of at least 10%, was calculated for 10-U incremental increases in eGFR cys and eGFR cr to ascertain prevalence rate ratios. This method was chosen given the relatively high percentage of nondipping in our cohort and the consequent concern that odds ratios would not accurately estimate relative risks.
We carried out sensitivity analyses testing for differences between those taking blood pressure medication and those who were not, as well as testing whether the presence of CKD, defined by both eGFR and the presence of microalbuminuria, was associated with dipping. We also considered whether albuminuria and eGFR cys might contribute separately to dipping behavior. To evaluate this, we explored linear models of systolic dipping, with albuminuria (expressed as log of the albumin/creatinine ratio) and eGFR included separately and then together, first in univariate analysis and then adjusted for demographic and clinical factors, as in our other models. We also examined associations between CKD cys and nocturnal blood pressure as a linear outcome, as opposed to dipping percentage, as some studies have shown nocturnal blood pressure to be most important for cardiovascular outcomes. We also compared separate cystatin C-based and creatinine-based CKD-EPI equations with the combined equation.
Finally, to examine the agreement between ABPM and in-clinic blood pressure measurement, we created Bland-Altman plots stratified by CKD status, from which the mean differences and 95% confidence intervals were identified. All analyses were carried out using SAS statistical software (release 9.3; SAS Institute Inc., Cary, North Carolina, USA); P-values less than 0.05 were considered significant.
Results
Baseline characteristics
There were 334 participants with a mean age of 72 6 years from whom ambulatory blood pressure data and cystatin C measurements were collected; 225 (67%) were female (Table 1) . Overall, the average eGFR cys was 78 20; 60 participants (18%) were classified as having CKD by the cystatin C equation. Compared with participants without CKD cys , those with CKD cys were older, more likely to be female, and more likely to have hypertension and diabetes. On average, participants with CKD cys had a higher BMI (29.9 vs. 26.7 kg/m 2 ). The mean in-clinic SBP and pulse pressure were significantly higher in those with CKD, but the mean in-clinic DBP was significantly lower. Similarly, the mean ambulatory pulse pressure was significantly higher in those with CKD, but the mean ambulatory DBP was significantly lower; the mean ambulatory SBP did not differ significantly between those with and those without CKD.
Those with CKD cys had a slightly increased ambulatory arterial stiffness index, indicating increased stiffness, and more variable blood pressure than those who did not have CKD cys . Albumin-creatinine ratios were relatively low in both groups.
Correlations
Correlation coefficients for eGFR and blood pressure measurements stratified by CKD status are provided in eGFR and ambulatory blood pressure in older adults Woodell et al. 89 Table 2 . In participants without CKD cys , eGFR cys was weakly correlated with systolic dipping but not with other ambulatory parameters or any clinic parameter. In participants with CKD cys , eGFR cys was not correlated with systolic dipping, but it was moderately and directly correlated with both the mean ambulatory DBP and the clinic DBP.
Associations between kidney function and blood pressure parameters
In unadjusted analysis, those with lower eGFR cys had a lower prevalence of normal dipping patterns ( Fig. 1) . Before adjustment, the presence of CKD cys , but not CKD cr , was associated with less dipping (per 1% point), a lower mean ambulatory DBP, and a higher mean ambulatory pulse pressure (Table 3a ). Associations were also identified between the presence of CKD cys and a higher mean clinic SBP and DBP. However, these effects were almost uniformly attenuated after full adjustment. In multivariate analysis, only an association between CKD cys status and the mean ambulatory DBP remained (− 2 mmHg, P = 0.048). We performed stepwise regression and determined that age and BMI were the primary confounders responsible for the attenuating effects on the multiple blood pressure parameters.
Kidney function and normal dipping pattern prevalence
In the unadjusted model, the prevalence of a normal dipping pattern significantly increased for every 10 ml/ min increment in either eGFR cys or eGFR cr (Table 4 ). This effect was attenuated to nonsignificance after adjustment for age and other confounders.
Agreement between ambulatory and clinic blood pressure
Regardless of CKD cys status, clinic SBP significantly overestimated the mean wake-time ambulatory SBP eGFR and ambulatory blood pressure in older adults Woodell et al. 91 (Fig. 2) ; the mean difference was 11 mmHg for those without CKD cys (95% limits of agreement − 14 to 35 mmHg) and 14 mmHg for those with CKD cys (95% limits of agreement − 13 to 41 mmHg). In contrast, clinic DBP accurately estimated the mean wake-time ambulatory DBP in both groups; the mean difference was 0 mmHg for those without CKD cys (95% limits of agreement − 14 to 14 mmHg) and 1 mmHg for those with CKD cys (95% limits of agreement − 14 to 15 mmHg). We identified 67 individuals in our cohort (36 of whom were taking antihypertensive therapy) who met the criteria for white-coat hypertension, defined by the European Society of Hypertension [20] as a clinic blood pressure of 140/90 mmHg or higher and a 24-h ambulatory blood pressure less than 130/80 mmHg; the prevalence of white-coat hypertension did not differ by CKD cys status.
Sensitivity analyses
To examine whether the utilization of antihypertensive medications affected the relationship between kidney function and blood pressure, we repeated linear regression and prevalence rate ratio analyses comparing those on antihypertensive therapy with those who were not (Table 3b) . No significant association existed for either antihypertensive therapy group between blood pressure and CKD cys status.
We carried out a separate analysis that included the presence of microalbuminuria in the definition of CKD. The findings were similar to those obtained for the eGFR-based definition of CKD cys , which did not include the presence or absence of microalbuminuria.
In analyses considering albuminuria and eGFR cys as separate factors, we found that, even in univariate models, the albumin/creatinine ratio had no association with systolic dipping [β-value for natural log of ACR, 0.62 (−0.41, 1.66), P = 0.23]. This remained the case in multivariate models, and adding ACR to a model with eGFR cys did not modify the β-coefficient for eGFR cys in unadjusted or adjusted models.
Sensitivity analysis was also carried out using the combined CKD-EPI equation for cystatin C and creatinine (CKD crcys ); results (not shown) were similar to those obtained using the cystatin-based equation.
Finally, we examined nocturnal blood pressure as a continuous variable rather than binary dipping or nondipping, with results again showing a statistically significant increase in nocturnal blood pressure that was attenuated by both age and BMI.
Discussion
CKD and hypertension are highly prevalent conditions that are frequently comorbid in older adults. In our study of community-dwelling older adults with predominantly mild CKD, we found that those with CKD had higher inclinic SBPs but only modest correlations between kidney function and ambulatory blood pressure parameters. After adjusting for multiple covariates, only a lower mean ambulatory DBP was significantly associated with CKD status; nocturnal dipping was not greater in those with normal versus abnormal kidney function. Finally, clinic SBPbut not clinic DBPwas significantly higher in comparison with ambulatory wake-time monitoring, and this difference was not affected by CKD status.
The finding that individuals with CKD had a significantly lower 24-h mean DBP is consistent with previous work demonstrating associations between CKD and lower in-clinic DBP [21] . Importantly, our study was performed in relatively healthy older adults without major illness and, hence, it generalizes this finding outside a purely hypertensive population and to 24-h measures rather than in-clinic measures.
We found it somewhat surprising that CKD in this cohort was not independently associated with dipping status after adjustment for age and other confounders. This finding may be because of the mild degree of CKD in our cohort (average eGFR cys in those with CKD was 47 ml/ min/1.73 m 2 and only four had eGFR cys less than 30 ml/ min/1.73 m 2 ). In cohorts with greater degrees of CKD, or end-stage renal disease, nondipping is common. Agarwal et al. [22] found a prevalence of nondipping of 75% among participants in a CKD clinic. It may be that only in more advanced disease are perturbations in blood pressure patterns observed.
We found that, after age adjustment, BMI was largely responsible for attenuating the relationship between CKD and abnormal blood pressure measurements, including dipping. One hypothesis to explain this observation may be that participants with higher BMI had both higher rates of CKD and subclinical obstructive sleep apnea (OSA). OSA is well established to be associated with nondipping [23, 24] . The prevalence of abnormal Epworth Sleepiness Scores among participants at the time of enrollment was modestly higher among individuals classified as having CKD, although adjusting for these scores did not change the associations beyond the contribution from BMI. However, many OSA patients do not report daytime sleepiness [25, 26] , and the correlation between OSA severity and Epworth Sleepiness Score is weak at best [27] , suggesting that OSA could still be a confounder in our study. Thus, further work is clearly needed.
We did not find an association between albuminuria, either when included as part of the CKD definition or when modeled alone, and systolic dipping; we believe that this may be because the levels of albuminuria in our cohort were very low. Although 25% of the cohort technically met the greater than 30 mg/g definition of microalbuminuria, 95% had microalbumin/creatinine ratios less than 70 mg/g, and only four individuals had macroalbuminuria, defined as ratios greater than 300 mg/g.
Compared with the mean ambulatory wake-time DBP, clinic DBP was a relatively accurate measurement, whereas clinic SBP significantly overestimated ambulatory wake-time SBP in comparison with ABPM findings. This observation did not differ by CKD status. Previous studies have described bias in in-clinic BP determinations, including white-coat hypertension [28] and the lack of a standardized approach to blood pressure measurement [29] . Our study shows this issue to be a problem both in those with and in those without CKD, as well as across the age range in our cohort. Bias in SBP and lack of precision in either SBP or DBP is more likely to lead to overtreatment based on in-clinic BP, as those who are labeled as 'hypertensive' are likely to receive medication. Our data add to the recognition that in-clinic SBP tends to overestimate out-of-office BP and demonstrate that this effect is independent of age or mild CKD. At least in this population, the use of ABPM, as may be recommended by the United States Preventive Services Task Force (USPSTF), would tend to decrease the number of individuals meeting the current criteria for hypertension treatment.
Our study has limitations. We do not have repeated measures of ABPM, nor do we have objective data on sleep or sleep quality. Moreover, our study was crosssectional, which precluded the ability to study the longitudinal relationships between CKD and blood pressure. Despite these limitations, our study also has several strengths. First, our participants were extensively characterized with regard to clinic and ambulatory blood pressure, kidney function, and medication use eGFR and ambulatory blood pressure in older adults Woodell et al. 93
concurrently, which allowed exploration of the potential role of multiple covariates. To our knowledge, this is the first study to evaluate the relationship between kidney disease defined by cystatin C and ABPM in communityliving older adults, and to examine the precision and accuracy of clinic versus ABPM in those with mild kidney disease defined by cystatin C. If ABPM comes into widespread clinical practice, as suggested by USPSTF, these insights will be important to inform clinical interpretation of ABPM in patients across the range of CKDs.
Conclusion
The presence of CKD was independently associated only with low ambulatory DBP and not with other blood pressure parameters, including dipping, in our cohort. Clinic DBP, but not SBP, was in agreement with waketime ABPM, and this was similar irrespective of CKD. Nonetheless, both clinic parameters lacked precision. Further studies may help clarify the role of ABPM in older individuals, including the longitudinal relationship between low DBP, kidney function, and adverse outcomes.
